会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof
    • 包含Erbb2变体的人类癌症干细胞培养组合物及其使用方法
    • US07737253B2
    • 2010-06-15
    • US11764752
    • 2007-06-18
    • Allan J. RobinsThomas C. Schulz
    • Allan J. RobinsThomas C. Schulz
    • C07K14/00C12N15/85
    • C12N5/0606C07K16/32C12N2501/195G01N33/5748G01N2333/71
    • The present invention provides compositions and methods for the culture and maintenance of cancer stem cells. More particularly, the present invention provides the identification of cancer stem cell specific markers and methods of recognizing the same for the detection of tumors, for facilitating the prognosis of a patient with a tumor, and for the treatment of various cancers. The invention also provides antibodies that specifically recognize the disulfide linked Erbb2Δ16 homodimer, an Erbb2Δ16/Erbb3 heterodimer, or post-translational modifications of Erbb2 that are specific to Erbb2 of variant hESCs. In addition, the invention provides a modified defined media useful in the absence of a feeder layer and in the absence of serum or serum replacement, that comprises a basal salt nutrient solution, bFGF, IGF-I, and Activin A, and wherein the composition does not comprise heregulin. The invention further relates to the use of an Erbb2 variant isoform to generate robust cell cultures that are independent of heregulin.
    • 本发明提供了用于培养和维持癌症干细胞的组合物和方法。 更具体地,本发明提供癌症干细胞特异性标志物的鉴定和识别癌症干细胞特异性标记物的方法以及用于检测肿瘤,促进肿瘤患者的预后和用于治疗各种癌症的方法。 本发明还提供了特异性识别二硫键连接的Erbb2和Dgr; 16同二聚体,Erbb2和Dgr; 16 / Erbb3异二聚体或Erbb2的翻译后修饰的抗体,其对变体hESC的Erbb2是特异性的。 此外,本发明提供了一种修饰的限定培养基,其在不存在饲养层且不存在血清或血清替代物的情况下可用,其包含基础盐营养溶液bFGF,IGF-I和活化素A,并且其中组合物 不包括蛋白质。 本发明还涉及使用Erbb2变体同种型来产生独立于调节蛋白的鲁棒细胞培养物。
    • 6. 发明申请
    • Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use
    • 人类癌症干细胞培养组合物包含ErbB2变体和使用方法
    • US20100279399A1
    • 2010-11-04
    • US12604942
    • 2009-10-23
    • Allan J. RobinsThomas C. Schulz
    • Allan J. RobinsThomas C. Schulz
    • C07K16/28C12N5/12
    • C12N5/0606C07K16/32C12N2501/195G01N33/5748G01N2333/71
    • The present invention provides compositions and methods for the culture and maintenance of cancer stem cells. More particularly, the present invention provides the identification of cancer stem cell specific markers and methods of recognizing the same for the detection of tumors, for facilitating the prognosis of a patient with a tumor, and for the treatment of various cancers. The invention also provides antibodies that specifically recognize the disulfide linked Erbb2Δ16 homodimer, an Erbb2Δ16/Erbb3 heterodimer, or post-translational modifications of Erbb2 that are specific to Erbb2 of variant hESCs, in addition, the invention provides a modified defined media useful in the absence of a feeder layer and in the absence of serum or serum replacement, that comprises a basal salt nutrient solution, bFGF, IGF-I, and Activin A, and wherein the composition does not comprise heregulin. The invention further relates to the use of an Erbb2 variant isoform to generate robust cell cultures that are independent of heregulin.
    • 本发明提供了用于培养和维持癌症干细胞的组合物和方法。 更具体地,本发明提供癌症干细胞特异性标志物的鉴定和识别癌症干细胞特异性标记物的方法以及用于检测肿瘤,促进肿瘤患者的预后和用于治疗各种癌症的方法。 本发明还提供了特异性识别二硫键连接的Erbb2和Dgr; 16同二聚体,Erbb2和Dgr; 16 / Erbb3异源二聚体的抗体或对变体hESC的Erbb2特异性的Erbb2的翻译后修饰,此外,本发明提供了修饰的定义的介质 在不存在饲养层的情况下和在不存在血清或血清替代物的情况下有用,其包含基础盐营养液,bFGF,IGF-1和活化素A,并且其中所述组合物不包含调味蛋白。 本发明还涉及使用Erbb2变体同种型来产生独立于调节蛋白的鲁棒细胞培养物。